This Week in Nature

In Nature Biotechnology this week, a group led by Foundation Medicine researchers report on a clinical cancer genomic profiling test that uses massively parallel DNA sequencing to help improve patient diagnosis. Using the sequencing technology, they characterized base substitutions, short insertions and deletions, copy number alterations, and selected fusions across 287 cancer-related genes from routine formalin-fixed and paraffin-embedded clinical specimens.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.